Danske Bank A S boosted its position in shares of Albemarle Corporation (NYSE:ALB – Free Report) by 56,770.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 227,482 shares of the specialty chemicals company’s stock after purchasing an additional 227,082 shares during the period. Danske Bank A S owned 0.19% of Albemarle worth $24,063,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ALB. Addison Advisors LLC purchased a new stake in shares of Albemarle in the second quarter valued at $28,000. Dakota Community Bank & Trust NA acquired a new stake in shares of Albemarle in the first quarter worth $54,000. Fiduciary Financial Advisors purchased a new position in shares of Albemarle during the second quarter valued at $41,000. Valley National Advisers Inc. grew its holdings in shares of Albemarle by 3,700.0% during the third quarter. Valley National Advisers Inc. now owns 304 shares of the specialty chemicals company’s stock valued at $32,000 after buying an additional 296 shares in the last quarter. Finally, Jones Financial Companies Lllp purchased a new position in shares of Albemarle during the second quarter valued at $42,000. 92.87% of the stock is currently owned by hedge funds and other institutional investors.
Albemarle Stock Down 5.9%
ALB opened at $88.03 on Tuesday. Albemarle Corporation has a fifty-two week low of $87.78 and a fifty-two week high of $221.00. The business has a 50-day moving average of $102.84 and a 200-day moving average of $145.08. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.34 and a quick ratio of 1.57. The company has a market capitalization of $10.39 billion, a PE ratio of 21.26, a price-to-earnings-growth ratio of 0.59 and a beta of 1.34.
Albemarle (NYSE:ALB – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The specialty chemicals company reported $2.58 EPS for the quarter, beating the consensus estimate of $2.53 by $0.05. Albemarle had a return on equity of 14.91% and a net margin of 10.40%. The business had revenue of $1.55 billion during the quarter, compared to analysts’ expectations of $1.52 billion. During the same quarter in the previous year, the business posted ($0.19) EPS. The firm’s quarterly revenue was up 18.8% compared to the same quarter last year. Equities research analysts forecast that Albemarle Corporation will post 10.64 EPS for the current fiscal year.
Albemarle Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, December 18th will be paid a $0.41 dividend. The ex-dividend date is Friday, December 18th. This represents a $1.64 dividend on an annualized basis and a yield of 1.9%. Albemarle’s payout ratio is 39.61%.
Analyst Upgrades and Downgrades
ALB has been the subject of several research analyst reports. JPMorgan Chase & Co. reduced their price objective on Albemarle from $160.00 to $140.00 and set a “neutral” rating for the company in a research note on Tuesday, August 25th. BMO Capital Markets decreased their price objective on Albemarle from $200.00 to $175.00 and set an “outperform” rating for the company in a research report on Tuesday, October 6th. Citigroup lifted their target price on Albemarle from $125.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, November 9th. Rothschild & Co Redburn dropped their target price on Albemarle from $100.00 to $86.00 in a report on Wednesday, November 11th. Finally, Bank of America reduced their price target on shares of Albemarle from $131.00 to $120.00 in a research report on Thursday, November 12th. Fifteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $152.63.
View Our Latest Research Report on ALB
About Albemarle
Albemarle Corporation is a specialty chemicals company that produces lithium, bromine and refining catalysts. Its products serve industries including energy storage, transportation, electronics, petroleum refining and pharmaceuticals. The company supplies lithium compounds used in rechargeable batteries and other applications. It also makes bromine-based products for uses such as flame retardants and water treatment, along with catalysts used in refining petroleum. Albemarle traces its history to 1887 and is headquartered in Charlotte, North Carolina.
See Also
- Five stocks we like better than Albemarle
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.
